Jim Frates

Jim Frates

Director of Finance/CFO en AMYLYX PHARMACEUTICALS, INC. .

Fortuna: 770 401 $ al 31/03/2024

56 años
Consumer Services
Commercial Services
Health Technology

Perfil

James M.
Frates
is currently the Director at St. Francis House, Independent Director at SAGE Therapeutics, Inc., and Chief Financial Officer at Amylyx Pharmaceuticals, Inc. He previously worked as the Director at GPC Biotech AG and National Director at The Association of Bioscience Financial Officers.
He was also the Vice President-Investment Banking at Robertson Stephens & Co. and the Chief Financial Officer & Senior Vice President at Alkermes Plc.
Frates has served as Treasurer & Trustee at St. Paul's School and Roxbury Latin School.
Frates holds an MBA degree from Harvard Business School and an undergraduate degree from Harvard College.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
16/04/2024 252 495 ( 0.37% ) 717 086 $ 31/03/2024
03/01/2024 2 845 ( 0.00% ) 53 315 $ 31/03/2024

Cargos activos de Jim Frates

EmpresasCargoInicio
SAGE THERAPEUTICS, INC. Director/Board Member 10/06/2014
AMYLYX PHARMACEUTICALS, INC. Director of Finance/CFO 01/01/2021
Director/Board Member -
Todos los cargos activos de Jim Frates

Antiguos cargos conocidos de Jim Frates.

EmpresasCargoFin
ALKERMES PLC Director of Finance/CFO 11/01/2021
Director/Board Member 01/06/2009
Director/Board Member 01/01/2009
Robertson Stephens & Co. Corporate Officer/Principal 01/06/1998
Roxbury Latin School Director/Board Member -
Ver el detalle de la experiencia de Jim Frates.

Formación de Jim Frates.

Harvard Business School Masters Business Admin
Harvard College Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Jim Frates.

Relaciones

97

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas3
SAGE THERAPEUTICS, INC.

Health Technology

AMYLYX PHARMACEUTICALS, INC.

Health Technology

ALKERMES PLC

Health Technology

Empresas privadas4

Commercial Services

Robertson Stephens & Co.

Finance

Commercial Services

Commercial Services

Ver las conexiones de la empresa